Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.84 +0.26%
EPS Growth %: +27.1%
Financial Fact:
Loss from discontinued operations, net of income tax benefit: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +27.1%
Financial Fact:
Loss from discontinued operations, net of income tax benefit: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.64, $0.39 better than the analyst estimate of $1.25. Revenue for the quarter came in at $695.8 million versus the consensus estimate of $595.88 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ladybug Resource Group updates M&A program, holds early financing talks
- Espey Manufacturing (ESP) Tops Q4 EPS by 24c
- 2G Energy receives 275 MW order from Energy Vault for U.S. data centers
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
